The results consistently showed that RANKL drives these cells to undergo EMT and assume many characteristics considered as metastatic cancer cell phenotypes, including the expression of mesenchymal and stem cell biomarkers, neuroendocrine and osteomimetic properties [46], gaining the propensity for metastasis to bone and soft tissues in mice [11]. Here, TNFSF11 is linked to cancer.